These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 9517632

  • 1. The circulating common gamma chain (CD132) in inflammatory bowel disease.
    Nielsen OH, Kirman I, Johnson K, Giedlin M, Ciardelli T.
    Am J Gastroenterol; 1998 Mar; 93(3):323-8. PubMed ID: 9517632
    [Abstract] [Full Text] [Related]

  • 2. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
    Nielsen OH, Ciardelli T, Wu Z, Langholz E, Kirman I.
    Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
    [Abstract] [Full Text] [Related]

  • 3. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
    Straub RH, Vogl D, Gross V, Lang B, Schölmerich J, Andus T.
    Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
    [Abstract] [Full Text] [Related]

  • 4. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
    Caradonna L, Amati L, Lella P, Jirillo E, Caccavo D.
    Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
    [Abstract] [Full Text] [Related]

  • 5. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A, Gasiorowska A, Małecka-Panas E.
    Pol Merkur Lekarski; 2004 Jun; 17 Suppl 1():22-6. PubMed ID: 15603341
    [Abstract] [Full Text] [Related]

  • 6. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J, Subrt I, Dìdek P, Siala K, Schwarz J, Machalová V, Varvarovská J, Pazdiora P, Pozler O, Stozický F.
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [Abstract] [Full Text] [Related]

  • 7. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S, Florin TH, Khalil D, Zhang MF, Patel K, Hamilton I, Hart DN.
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [Abstract] [Full Text] [Related]

  • 8. Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases.
    Ludwiczek O, Kaser A, Tilg H.
    Int J Colorectal Dis; 2003 Mar; 18(2):142-7. PubMed ID: 12548417
    [Abstract] [Full Text] [Related]

  • 9. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH, Stempak JM, Xu W, Lan H, Griffiths AM, Greenberg GR, Steinhart AH, Dotan N, Silverberg MS.
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis.
    Kirman I, Nielsen OH.
    Am J Gastroenterol; 1996 Sep; 91(9):1789-94. PubMed ID: 8792700
    [Abstract] [Full Text] [Related]

  • 15. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.
    Koutroubakis IE, Sfiridaki A, Tsiolakidou G, Coucoutsi C, Theodoropoulou A, Kouroumalis EA.
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):912-6. PubMed ID: 18794606
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T, Lemmers A, Louis E, Nicaise C, Quertinmont E, Belaiche J, Roland S, Van Gossum A, Devière J, Franchimont D.
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [Abstract] [Full Text] [Related]

  • 18. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ, Nickerson P, Bernstein CN.
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum tumor necrosis factor activity in inflammatory bowel disease.
    Maeda M, Watanabe N, Neda H, Yamauchi N, Okamoto T, Sasaki H, Tsuji Y, Akiyama S, Tsuji N, Niitsu Y.
    Immunopharmacol Immunotoxicol; 1992 May; 14(3):451-61. PubMed ID: 1517530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.